CS614388A2 - Method of pharmaceutical agent production - Google Patents

Method of pharmaceutical agent production

Info

Publication number
CS614388A2
CS614388A2 CS886143A CS614388A CS614388A2 CS 614388 A2 CS614388 A2 CS 614388A2 CS 886143 A CS886143 A CS 886143A CS 614388 A CS614388 A CS 614388A CS 614388 A2 CS614388 A2 CS 614388A2
Authority
CS
Czechoslovakia
Prior art keywords
pharmaceutical agent
agent production
production
pharmaceutical
agent
Prior art date
Application number
CS886143A
Other languages
English (en)
Other versions
CS274435B2 (en
Inventor
Anders R Sorensen
Anne Engesgaard
Philip E Hansen
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK477487A external-priority patent/DK477487D0/da
Priority claimed from DK682587A external-priority patent/DK682587D0/da
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of CS614388A2 publication Critical patent/CS614388A2/cs
Publication of CS274435B2 publication Critical patent/CS274435B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
CS614388A 1987-09-14 1988-09-14 Method of pharmaceutical agent production CS274435B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK477487A DK477487D0 (da) 1987-09-14 1987-09-14 Praeparat
DK682587A DK682587D0 (da) 1987-12-23 1987-12-23 Praeparat til non-parenteral administration og fremgangsmaade til dets fremstilling

Publications (2)

Publication Number Publication Date
CS614388A2 true CS614388A2 (en) 1990-08-14
CS274435B2 CS274435B2 (en) 1991-04-11

Family

ID=26067617

Family Applications (1)

Application Number Title Priority Date Filing Date
CS614388A CS274435B2 (en) 1987-09-14 1988-09-14 Method of pharmaceutical agent production

Country Status (11)

Country Link
EP (1) EP0308181A1 (cs)
JP (1) JPH03502920A (cs)
KR (1) KR890701137A (cs)
CN (1) CN1031940A (cs)
AU (1) AU2481688A (cs)
CS (1) CS274435B2 (cs)
FI (1) FI901256A7 (cs)
HU (1) HUT53281A (cs)
PT (1) PT88490B (cs)
WO (1) WO1989002279A1 (cs)
YU (1) YU173088A (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005535A1 (fr) * 1988-11-14 1990-05-31 Otsuka Pharmaceutical Co., Ltd. Preparation a base d'interferon pour administration nasale
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
GB9012663D0 (en) * 1990-06-07 1990-08-01 Erba Carlo Spa Galenic formulations containing cyclodextrins
IT1248725B (it) * 1990-06-12 1995-01-26 Sclavo Spa Composizione farmaceutica in polvere per somministrazione per via nasale contenente essenzialmente calcitonina ed un eccipiente idrosolubile
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
NL9001681A (nl) * 1990-07-24 1992-02-17 Rijksuniversiteit Transmucosale geneesmiddelpreparaten en transmucosale toediening.
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
BE1006873A6 (nl) * 1993-03-26 1995-01-10 Merkus Franciscus W H M Toedieningsformulering voor nasale insuline toediening.
IL109350A (en) * 1993-05-12 2001-01-28 Genentech Inc Stable liquid compositions of gamma interferon
AU2104097A (en) * 1996-03-13 1997-10-01 Glaxo Group Limited Medicaments comprising 5ht1-like receptor agonists with an increased absorption
WO1998046269A1 (en) 1997-04-14 1998-10-22 Tt Pharmaceuticals, Inc. Permucous preparation
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AU3055099A (en) 1998-05-20 1999-12-06 Charna Chemicals Ltd. A pharmaceutical formulation for nasal administration
EP0998940A1 (en) * 1998-09-30 2000-05-10 Laboratoire Theramex Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US20040258663A1 (en) * 2003-05-08 2004-12-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of interferon alpha
US20050143303A1 (en) * 2003-12-26 2005-06-30 Nastech Pharmaceutical Company Inc. Intranasal administration of glucose-regulating peptides
CN1299770C (zh) * 2004-05-31 2007-02-14 刘近周 多功能鼻腔和鼻窦洁疗液
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
SE533540C2 (sv) 2008-12-19 2010-10-19 Neoinvent Medical Engineering Ab Administrerinssystem för administrering av en substans i munhålan
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
CA2781792C (en) 2009-11-25 2019-04-02 Boehringer Ingelheim International Gmbh Nebulizer
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
MX385713B (es) 2013-03-13 2025-03-18 Seagen Inc Ciclodextrina y formulaciones de conjugados anticuerpo-fármaco.
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
SG11201608891RA (en) 2014-05-07 2016-11-29 Boehringer Ingelheim Int Nebulizer, indicator device and container
BR112016023983B1 (pt) 2014-05-07 2022-10-18 Boehringer Ingelheim International Gmbh Contentor para um nebulizador, nebulizador para um fluido e método para conectar um contentor a um dispositivo indicador
MA52253A (fr) * 2015-02-17 2021-02-17 Lilly Co Eli Formulation de poudre nasale pour le traitement de l'hypoglycémie
BR112023020961A2 (pt) 2021-04-11 2023-12-12 Elgan Pharma Ltd Formulações de insulina e métodos para usar a mesma em bebês prematuros

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6322173A (en) * 1972-12-05 1975-06-05 Ono Pharmaceutical Co Prostaglandin compositions
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
DE3302319A1 (de) * 1983-01-25 1984-08-16 Karl Eugen Prof. Dr.Med. Theurer Verfahren zur konservierung, stabilisierung und resorptionsverbesserung von therapeutisch anzuwendenden zell- und organbestandteilen
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS61126034A (ja) * 1984-11-26 1986-06-13 Yamanouchi Pharmaceut Co Ltd アルド−スを含有するカルシトニン経鼻剤
US4727077A (en) * 1985-02-20 1988-02-23 Ishihara Sangyo Kaisha Ltd. Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
NZ222907A (en) * 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
JPS63196524A (ja) * 1987-02-10 1988-08-15 Wakunaga Pharmaceut Co Ltd 経粘膜吸収型制ガン作用調節剤

Also Published As

Publication number Publication date
HUT53281A (en) 1990-10-28
HU885826D0 (en) 1990-09-28
FI901256A0 (fi) 1990-03-13
CS274435B2 (en) 1991-04-11
FI901256A7 (fi) 1990-03-13
AU2481688A (en) 1989-04-17
PT88490A (pt) 1988-10-01
EP0308181A1 (en) 1989-03-22
CN1031940A (zh) 1989-03-29
JPH03502920A (ja) 1991-07-04
YU173088A (en) 1990-06-30
PT88490B (pt) 1992-11-30
WO1989002279A1 (en) 1989-03-23
KR890701137A (ko) 1989-12-19

Similar Documents

Publication Publication Date Title
CS614388A2 (en) Method of pharmaceutical agent production
HUT51272A (en) Process for producing thiadiazin derivatives and pharmaceutical composirions containing them
PL275089A1 (en) Method of obtaining novel pharmaceutical compositions
HUT52560A (en) Process for production of plasmide-vectors
CS8801469A2 (en) Method of substituted benzamides production
PL274216A1 (en) Method of manufacture of derivatives of imidazepiridazine
CS96488A2 (en) Method of arylpiperazinyl-alkylenphenyl-heterocyclic compounds production
CS938384A1 (en) Pharmaceutical agent for breathlesness therapy and method of its production
EP0301346A3 (en) Production of polyfluorbutenes
HUT49143A (en) Process for production of d-arabinase
JPS6461495A (en) Production of 2-deoxynucleotide
JPS6426588A (en) Production of eraiophiline
CS591188A2 (en) Method of spiroimidazolidinedione production
CS40588A2 (en) Method of new isoxale derivatives production
CS415888A2 (en) Method of new acylderivatives production
CS910288A2 (en) Method of dioxazocine's derivatives production
GB8722461D0 (en) Production of methhnol
HUT37430A (en) Process for the production of pteridin-derivatives of pharmaceutical effect
HUT48569A (en) Process for production of caprioil-oxi-alkyl acrilates and their polimers and copolimers
CS225587A1 (en) Method of fasade production
CS236489A2 (en) Method of 7-fluor-1-methyl-3-methylthio-4-quinolone production
CS970587A1 (en) Method of dithioalkandioles production
CS779387A1 (en) Method of ferroliquid production
CS421987A1 (en) Method of m-aminophenylurea production
CS990687A1 (en) Method of sulfonophtaleins production